As we look to ways with which to bring down costs, I am absolutely convinced that a big part of that effort... will be determined by the degree to which generic drugs are allowed to play the role that it can.
Daschle emphasizes the importance of generic drugs in reducing healthcare costs.
Share
More from Thomas Daschle
I have a sense that the time has come for real constructive bipartisan action on healthcare.
We have cost problems. We have access problems. But as you rightfully point out in your question, we certainly have quality problems.
I want to re-instate a science-driven environment. I want to take ideology and politics as much as humanly possible out of the process.
The American people, by survey after survey, say they want these tax loopholes closed when they are informed particularly of the loopholes which allow corporations to shift revenue to a tax haven.
Other voices in this conversation
